Galderma Investigational Site 8142

Indianapolis, Indiana 46250-2041

2 studies enrolling now · 5 studies all time

What they study most

Atopic Dermatitis, Moderate-to-Severe Atopic Dermatitis, Prurigo Nodularis

Studies at this site

• Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults — Recruiting now
• Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults — Recruiting now
• Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis — Completed
• Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis — Running, not enrolling
• Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis — Completed